Edward Dempsey
Concepts (333)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neprilysin | 6 | 2017 | 47 | 2.590 |
Why?
| Muscle, Smooth, Vascular | 22 | 2017 | 454 | 2.430 |
Why?
| Protein Kinase C | 15 | 2007 | 314 | 1.900 |
Why?
| Pulmonary Artery | 26 | 2020 | 1097 | 1.880 |
Why?
| Hypoxia | 18 | 2021 | 1003 | 1.410 |
Why?
| rho GTP-Binding Proteins | 2 | 2020 | 68 | 1.310 |
Why?
| Pulmonary Circulation | 7 | 2009 | 455 | 1.020 |
Why?
| Isoenzymes | 9 | 2007 | 303 | 0.780 |
Why?
| Hypertension, Pulmonary | 12 | 2021 | 1900 | 0.730 |
Why?
| Lung | 11 | 2021 | 3830 | 0.710 |
Why?
| Evans Blue | 1 | 2018 | 7 | 0.680 |
Why?
| Capillary Permeability | 1 | 2018 | 148 | 0.640 |
Why?
| Cell Division | 25 | 2009 | 788 | 0.610 |
Why?
| Protein Kinase C-epsilon | 3 | 2005 | 31 | 0.600 |
Why?
| Myocytes, Smooth Muscle | 2 | 2019 | 244 | 0.580 |
Why?
| Muscle Proteins | 1 | 2017 | 218 | 0.550 |
Why?
| Blood Vessels | 3 | 2016 | 193 | 0.530 |
Why?
| Endothelium, Vascular | 2 | 2020 | 923 | 0.460 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 25 | 0.450 |
Why?
| Aging | 4 | 2020 | 1694 | 0.450 |
Why?
| Mice, Knockout | 6 | 2017 | 2737 | 0.440 |
Why?
| Animals | 44 | 2021 | 34133 | 0.440 |
Why?
| Animals, Newborn | 10 | 2007 | 825 | 0.400 |
Why?
| Airway Remodeling | 1 | 2010 | 58 | 0.380 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1265 | 0.310 |
Why?
| Cattle | 16 | 2002 | 994 | 0.310 |
Why?
| Fibroblasts | 7 | 2019 | 846 | 0.300 |
Why?
| Mice | 14 | 2018 | 15888 | 0.290 |
Why?
| Endothelin-1 | 2 | 2017 | 170 | 0.260 |
Why?
| Protein Kinases | 1 | 2007 | 325 | 0.260 |
Why?
| Signal Transduction | 7 | 2020 | 4902 | 0.250 |
Why?
| Lung Neoplasms | 11 | 2012 | 2216 | 0.250 |
Why?
| Enzyme Activation | 5 | 2017 | 864 | 0.230 |
Why?
| rho-Associated Kinases | 2 | 2019 | 85 | 0.230 |
Why?
| Vascular Remodeling | 2 | 2021 | 158 | 0.220 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2002 | 50 | 0.220 |
Why?
| Insulin-Like Growth Factor I | 3 | 1997 | 288 | 0.220 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2012 | 90 | 0.220 |
Why?
| Mice, Inbred C57BL | 5 | 2017 | 5020 | 0.220 |
Why?
| Lung Diseases | 2 | 2007 | 764 | 0.220 |
Why?
| Cells, Cultured | 12 | 2017 | 4162 | 0.220 |
Why?
| Growth Substances | 4 | 1997 | 140 | 0.200 |
Why?
| Vasoconstriction | 1 | 2002 | 216 | 0.200 |
Why?
| Tetradecanoylphorbol Acetate | 5 | 1997 | 162 | 0.200 |
Why?
| Cell Movement | 3 | 2017 | 929 | 0.200 |
Why?
| Butyrates | 1 | 2021 | 55 | 0.200 |
Why?
| Proto-Oncogene Proteins c-myc | 2 | 2020 | 122 | 0.200 |
Why?
| Metabolic Diseases | 1 | 2021 | 104 | 0.190 |
Why?
| Mitogens | 2 | 1997 | 61 | 0.190 |
Why?
| Forkhead Box Protein O3 | 1 | 2020 | 17 | 0.190 |
Why?
| Phenotype | 5 | 2017 | 3070 | 0.180 |
Why?
| Platelet-Derived Growth Factor | 3 | 1997 | 85 | 0.180 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2021 | 207 | 0.180 |
Why?
| Vasa Vasorum | 1 | 2020 | 34 | 0.180 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 156 | 0.180 |
Why?
| rhoA GTP-Binding Protein | 1 | 2019 | 80 | 0.170 |
Why?
| Cellular Microenvironment | 1 | 2019 | 82 | 0.170 |
Why?
| Metabolome | 1 | 2021 | 299 | 0.170 |
Why?
| Pulmonary Alveoli | 2 | 2012 | 395 | 0.160 |
Why?
| Genotype | 2 | 2017 | 1943 | 0.160 |
Why?
| Thymidine | 5 | 1996 | 64 | 0.160 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2017 | 14 | 0.160 |
Why?
| Smooth Muscle Myosins | 1 | 2017 | 9 | 0.160 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2017 | 57 | 0.150 |
Why?
| Actins | 3 | 2017 | 409 | 0.150 |
Why?
| Microfilament Proteins | 1 | 2017 | 135 | 0.150 |
Why?
| Substance P | 1 | 2016 | 44 | 0.140 |
Why?
| Doxycycline | 1 | 2016 | 60 | 0.140 |
Why?
| Calcium-Binding Proteins | 1 | 2017 | 222 | 0.140 |
Why?
| Duodenum | 1 | 2016 | 65 | 0.140 |
Why?
| Vascular Diseases | 1 | 2019 | 251 | 0.140 |
Why?
| Chronic Disease | 6 | 2009 | 1645 | 0.140 |
Why?
| Pneumonia | 1 | 2021 | 605 | 0.140 |
Why?
| Neovascularization, Pathologic | 5 | 2020 | 292 | 0.130 |
Why?
| Sleep Apnea Syndromes | 2 | 2013 | 88 | 0.130 |
Why?
| Uterus | 3 | 2006 | 197 | 0.130 |
Why?
| Carcinogens | 2 | 2012 | 110 | 0.130 |
Why?
| Cell Communication | 1 | 1996 | 287 | 0.120 |
Why?
| In Vitro Techniques | 5 | 2007 | 1130 | 0.120 |
Why?
| Sputum | 3 | 2005 | 293 | 0.120 |
Why?
| Humans | 30 | 2021 | 122796 | 0.120 |
Why?
| Myocardium | 1 | 2019 | 982 | 0.120 |
Why?
| Endothelial Cells | 3 | 2021 | 749 | 0.120 |
Why?
| Estradiol | 2 | 1997 | 477 | 0.120 |
Why?
| Enzyme Inhibitors | 4 | 2002 | 836 | 0.110 |
Why?
| Piperidines | 2 | 2012 | 169 | 0.110 |
Why?
| Quinazolines | 2 | 2012 | 243 | 0.110 |
Why?
| Cell Proliferation | 2 | 2017 | 2328 | 0.110 |
Why?
| Gene Expression Regulation, Developmental | 1 | 1997 | 852 | 0.110 |
Why?
| Blotting, Western | 3 | 2012 | 1225 | 0.110 |
Why?
| Gene Expression Regulation | 3 | 2016 | 2491 | 0.100 |
Why?
| Mice, Transgenic | 1 | 2016 | 2079 | 0.100 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2005 | 294 | 0.100 |
Why?
| Bronchoscopy | 5 | 2009 | 254 | 0.100 |
Why?
| Somatomedins | 1 | 1990 | 27 | 0.100 |
Why?
| DNA Primers | 2 | 2009 | 540 | 0.090 |
Why?
| Carcinoma in Situ | 3 | 2005 | 45 | 0.090 |
Why?
| Arteries | 2 | 2006 | 256 | 0.090 |
Why?
| Precancerous Conditions | 3 | 2004 | 164 | 0.090 |
Why?
| Maleimides | 3 | 2000 | 24 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 1859 | 0.090 |
Why?
| Tocopherols | 1 | 2009 | 20 | 0.090 |
Why?
| Isotretinoin | 1 | 2009 | 23 | 0.090 |
Why?
| Biomarkers | 1 | 2020 | 3662 | 0.090 |
Why?
| ErbB Receptors | 1 | 2012 | 571 | 0.080 |
Why?
| Cell Hypoxia | 3 | 1999 | 229 | 0.080 |
Why?
| Blood Pressure | 3 | 2021 | 1713 | 0.080 |
Why?
| Biomarkers, Tumor | 3 | 2012 | 1076 | 0.080 |
Why?
| Female | 17 | 2012 | 63629 | 0.080 |
Why?
| Indoles | 3 | 2000 | 318 | 0.070 |
Why?
| Carcinoma, Squamous Cell | 2 | 2005 | 622 | 0.070 |
Why?
| Galectin 1 | 1 | 2006 | 2 | 0.070 |
Why?
| Bronchi | 2 | 2000 | 253 | 0.070 |
Why?
| Male | 10 | 2018 | 59639 | 0.070 |
Why?
| Genes, ras | 2 | 1997 | 99 | 0.070 |
Why?
| Videotape Recording | 1 | 2006 | 36 | 0.070 |
Why?
| Hyperoxia | 1 | 2007 | 112 | 0.070 |
Why?
| Heart Failure | 1 | 2019 | 2114 | 0.070 |
Why?
| Thiazolidinediones | 1 | 2006 | 155 | 0.070 |
Why?
| Rats, Sprague-Dawley | 3 | 2021 | 2501 | 0.070 |
Why?
| Disease Models, Animal | 2 | 2013 | 3799 | 0.070 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2021 | 148 | 0.070 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2005 | 171 | 0.060 |
Why?
| Smoking | 4 | 2009 | 1556 | 0.060 |
Why?
| DNA | 4 | 1997 | 1401 | 0.060 |
Why?
| Blood | 2 | 1995 | 100 | 0.060 |
Why?
| Endothelins | 2 | 1996 | 62 | 0.060 |
Why?
| Rats | 4 | 2021 | 5426 | 0.060 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2005 | 198 | 0.060 |
Why?
| Drug Synergism | 3 | 1996 | 346 | 0.060 |
Why?
| Drug Delivery Systems | 1 | 2007 | 312 | 0.060 |
Why?
| Calcium | 2 | 2002 | 1244 | 0.060 |
Why?
| Guinea Pigs | 3 | 2006 | 152 | 0.060 |
Why?
| Hemodynamics | 1 | 2009 | 1036 | 0.060 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 1997 | 633 | 0.060 |
Why?
| Shaw Potassium Channels | 1 | 2002 | 4 | 0.060 |
Why?
| Fetus | 2 | 1997 | 699 | 0.060 |
Why?
| Potassium Chloride | 1 | 2002 | 44 | 0.060 |
Why?
| Potassium Channel Blockers | 1 | 2002 | 35 | 0.060 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 432 | 0.060 |
Why?
| Case-Control Studies | 1 | 2010 | 3296 | 0.060 |
Why?
| Stem Cells | 1 | 2007 | 576 | 0.050 |
Why?
| Angiotensin II | 1 | 2002 | 108 | 0.050 |
Why?
| Potassium Channels | 1 | 2002 | 137 | 0.050 |
Why?
| Nitric Oxide Synthase | 1 | 2002 | 227 | 0.050 |
Why?
| Tunica Media | 2 | 1998 | 38 | 0.050 |
Why?
| Urethane | 2 | 2012 | 40 | 0.050 |
Why?
| Protein Kinase C beta | 2 | 2000 | 26 | 0.050 |
Why?
| Antineoplastic Agents | 2 | 2010 | 1990 | 0.050 |
Why?
| Systole | 1 | 2021 | 178 | 0.050 |
Why?
| Gene Deletion | 1 | 2002 | 365 | 0.050 |
Why?
| Tight Junctions | 1 | 2021 | 70 | 0.050 |
Why?
| Fluorescence | 1 | 2001 | 164 | 0.050 |
Why?
| Macrophages | 2 | 2021 | 1334 | 0.050 |
Why?
| Patient Education as Topic | 1 | 2006 | 717 | 0.050 |
Why?
| Microvessels | 1 | 2021 | 76 | 0.050 |
Why?
| Acetylation | 1 | 2021 | 227 | 0.050 |
Why?
| Aged | 6 | 2010 | 20495 | 0.050 |
Why?
| Receptors, Purinergic P2Y | 1 | 2020 | 7 | 0.050 |
Why?
| Nitric Oxide | 1 | 2005 | 884 | 0.050 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2359 | 0.050 |
Why?
| Ligands | 1 | 2021 | 582 | 0.040 |
Why?
| Cytokines | 2 | 2021 | 1928 | 0.040 |
Why?
| GTPase-Activating Proteins | 1 | 2019 | 75 | 0.040 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 61 | 0.040 |
Why?
| Trans-Activators | 1 | 2001 | 382 | 0.040 |
Why?
| Light | 1 | 2001 | 346 | 0.040 |
Why?
| Neoplasms | 1 | 2013 | 2235 | 0.040 |
Why?
| Leukocytes | 1 | 2019 | 295 | 0.040 |
Why?
| Immune System | 1 | 2019 | 184 | 0.040 |
Why?
| Up-Regulation | 1 | 2021 | 891 | 0.040 |
Why?
| Oxygen | 1 | 2002 | 887 | 0.040 |
Why?
| Aorta | 2 | 2001 | 368 | 0.040 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 358 | 0.040 |
Why?
| Culture Media, Serum-Free | 1 | 1997 | 41 | 0.040 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 1997 | 35 | 0.040 |
Why?
| Adenosine Triphosphate | 1 | 2020 | 456 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 433 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2019 | 343 | 0.040 |
Why?
| Protein Kinase C-alpha | 1 | 1997 | 43 | 0.040 |
Why?
| Ischemia | 1 | 2000 | 382 | 0.040 |
Why?
| Middle Aged | 5 | 2010 | 28563 | 0.040 |
Why?
| Organ Specificity | 1 | 1997 | 287 | 0.040 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2020 | 377 | 0.040 |
Why?
| Pregnancy, Animal | 1 | 1997 | 58 | 0.040 |
Why?
| Nuclear Proteins | 1 | 2001 | 618 | 0.040 |
Why?
| Bronchial Neoplasms | 1 | 1996 | 16 | 0.040 |
Why?
| Muscle Development | 1 | 1997 | 106 | 0.040 |
Why?
| Sensitivity and Specificity | 2 | 2001 | 1855 | 0.040 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 592 | 0.040 |
Why?
| Rabbits | 1 | 1997 | 808 | 0.040 |
Why?
| Species Specificity | 1 | 1997 | 578 | 0.040 |
Why?
| Microcirculation | 2 | 2007 | 162 | 0.040 |
Why?
| Blood Physiological Phenomena | 1 | 1996 | 15 | 0.040 |
Why?
| Tritium | 1 | 1996 | 71 | 0.040 |
Why?
| Receptors, Platelet-Derived Growth Factor | 1 | 1996 | 13 | 0.040 |
Why?
| Point Mutation | 1 | 1997 | 231 | 0.030 |
Why?
| Heart Ventricles | 1 | 2021 | 741 | 0.030 |
Why?
| Neoplasms, Second Primary | 1 | 1997 | 91 | 0.030 |
Why?
| Rats, Inbred Strains | 1 | 1996 | 392 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 2 | 2010 | 1981 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 1996 | 390 | 0.030 |
Why?
| Exercise | 1 | 2006 | 1743 | 0.030 |
Why?
| Myocytes, Cardiac | 1 | 2019 | 483 | 0.030 |
Why?
| Protein Precursors | 1 | 1996 | 126 | 0.030 |
Why?
| Catalysis | 1 | 1995 | 295 | 0.030 |
Why?
| Quality of Life | 1 | 2006 | 2457 | 0.030 |
Why?
| Young Adult | 1 | 2010 | 11094 | 0.030 |
Why?
| Subcellular Fractions | 1 | 1994 | 86 | 0.030 |
Why?
| Adenosine Diphosphate | 1 | 1994 | 89 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 985 | 0.030 |
Why?
| Flow Cytometry | 2 | 1996 | 1128 | 0.030 |
Why?
| Stress, Mechanical | 1 | 1996 | 440 | 0.030 |
Why?
| Poly I-C | 1 | 1994 | 55 | 0.030 |
Why?
| Models, Biological | 1 | 2021 | 1756 | 0.030 |
Why?
| Recombinant Proteins | 1 | 1997 | 1318 | 0.030 |
Why?
| Blood Proteins | 1 | 1996 | 249 | 0.030 |
Why?
| Endothelin Receptor Antagonists | 1 | 1993 | 64 | 0.030 |
Why?
| Hyperplasia | 2 | 2006 | 169 | 0.030 |
Why?
| Complement Factor B | 1 | 1994 | 102 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 1996 | 388 | 0.030 |
Why?
| Neoplasm Proteins | 1 | 1996 | 415 | 0.030 |
Why?
| Risk Factors | 5 | 2009 | 9381 | 0.030 |
Why?
| Extracellular Matrix | 2 | 2006 | 461 | 0.030 |
Why?
| Methylcholanthrene | 1 | 2012 | 18 | 0.030 |
Why?
| Butylated Hydroxytoluene | 1 | 2012 | 31 | 0.030 |
Why?
| Serotonin | 1 | 1994 | 311 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 201 | 0.030 |
Why?
| Adolescent | 1 | 2010 | 18948 | 0.030 |
Why?
| Pregnancy | 3 | 2006 | 5854 | 0.030 |
Why?
| Peptides, Cyclic | 1 | 1993 | 260 | 0.030 |
Why?
| Blood Platelets | 1 | 1994 | 369 | 0.030 |
Why?
| Phorbol 12,13-Dibutyrate | 1 | 1991 | 11 | 0.030 |
Why?
| Aerobiosis | 1 | 1991 | 23 | 0.020 |
Why?
| Cell Count | 2 | 2006 | 319 | 0.020 |
Why?
| Time Factors | 2 | 2007 | 6682 | 0.020 |
Why?
| Anaerobiosis | 1 | 1991 | 51 | 0.020 |
Why?
| Infant, Newborn | 2 | 2007 | 5430 | 0.020 |
Why?
| Dimethyl Sulfoxide | 1 | 1991 | 45 | 0.020 |
Why?
| Apoptosis | 1 | 2000 | 2532 | 0.020 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2012 | 182 | 0.020 |
Why?
| Tumor Cells, Cultured | 3 | 1996 | 904 | 0.020 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 240 | 0.020 |
Why?
| Protein Binding | 1 | 1996 | 2010 | 0.020 |
Why?
| Chemoprevention | 1 | 2010 | 99 | 0.020 |
Why?
| Biopsy | 2 | 2005 | 1090 | 0.020 |
Why?
| DNA Replication | 1 | 1991 | 214 | 0.020 |
Why?
| Antioxidants | 1 | 2012 | 581 | 0.020 |
Why?
| RNA, Messenger | 1 | 1996 | 2720 | 0.020 |
Why?
| Down-Regulation | 1 | 1990 | 654 | 0.020 |
Why?
| Leukocyte Common Antigens | 1 | 2007 | 84 | 0.020 |
Why?
| Molecular Targeted Therapy | 1 | 2010 | 361 | 0.020 |
Why?
| Kinetics | 1 | 1991 | 1658 | 0.020 |
Why?
| Rats, Inbred WKY | 1 | 2006 | 39 | 0.020 |
Why?
| Elastin | 1 | 2006 | 78 | 0.020 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 61 | 0.020 |
Why?
| Codon | 2 | 1997 | 90 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2009 | 6845 | 0.020 |
Why?
| Serum | 1 | 2006 | 65 | 0.020 |
Why?
| PPAR gamma | 1 | 2006 | 191 | 0.020 |
Why?
| Vascular Resistance | 1 | 2006 | 374 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2006 | 551 | 0.020 |
Why?
| Collagen | 1 | 2006 | 436 | 0.020 |
Why?
| Protein Kinase Inhibitors | 1 | 2010 | 833 | 0.020 |
Why?
| Sheep | 1 | 2006 | 769 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2010 | 1306 | 0.010 |
Why?
| Polymerase Chain Reaction | 2 | 1997 | 1021 | 0.010 |
Why?
| Neoplasm Invasiveness | 1 | 2005 | 472 | 0.010 |
Why?
| Adenocarcinoma | 1 | 2010 | 837 | 0.010 |
Why?
| Neoplasm Recurrence, Local | 1 | 2009 | 903 | 0.010 |
Why?
| Teaching | 1 | 2006 | 241 | 0.010 |
Why?
| Vital Capacity | 1 | 2004 | 277 | 0.010 |
Why?
| Confidence Intervals | 1 | 2004 | 339 | 0.010 |
Why?
| Activities of Daily Living | 1 | 2006 | 361 | 0.010 |
Why?
| Epithelial Cells | 2 | 2001 | 995 | 0.010 |
Why?
| Gestational Age | 1 | 2006 | 787 | 0.010 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2007 | 337 | 0.010 |
Why?
| Forced Expiratory Volume | 1 | 2004 | 562 | 0.010 |
Why?
| Base Sequence | 1 | 2006 | 2186 | 0.010 |
Why?
| Patient Compliance | 1 | 2006 | 561 | 0.010 |
Why?
| Metaplasia | 1 | 2001 | 59 | 0.010 |
Why?
| CREB-Binding Protein | 1 | 2001 | 29 | 0.010 |
Why?
| Adaptation, Psychological | 1 | 2006 | 569 | 0.010 |
Why?
| Single-Blind Method | 1 | 2001 | 275 | 0.010 |
Why?
| Fluorescent Antibody Technique | 1 | 2001 | 420 | 0.010 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2000 | 51 | 0.010 |
Why?
| Loss of Heterozygosity | 1 | 2000 | 40 | 0.010 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2000 | 59 | 0.010 |
Why?
| Ki-67 Antigen | 1 | 2000 | 114 | 0.010 |
Why?
| Carcinoma | 1 | 2001 | 212 | 0.010 |
Why?
| Fibrosis | 1 | 2002 | 497 | 0.010 |
Why?
| Airway Obstruction | 1 | 2001 | 182 | 0.010 |
Why?
| Risk | 1 | 2001 | 890 | 0.010 |
Why?
| Prevalence | 1 | 2005 | 2442 | 0.010 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 1997 | 967 | 0.010 |
Why?
| Cell Death | 1 | 2000 | 345 | 0.010 |
Why?
| Mitotic Index | 1 | 1997 | 29 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1997 | 78 | 0.010 |
Why?
| Cytoskeletal Proteins | 1 | 1997 | 147 | 0.010 |
Why?
| Tunica Intima | 1 | 1997 | 79 | 0.010 |
Why?
| Myosins | 1 | 1997 | 130 | 0.010 |
Why?
| Chromosome Banding | 1 | 1996 | 18 | 0.010 |
Why?
| Mammals | 1 | 1999 | 257 | 0.010 |
Why?
| Ploidies | 1 | 1996 | 18 | 0.010 |
Why?
| Ovariectomy | 1 | 1997 | 125 | 0.010 |
Why?
| Karyotyping | 1 | 1996 | 102 | 0.010 |
Why?
| Ligases | 1 | 1996 | 33 | 0.010 |
Why?
| Comorbidity | 1 | 2001 | 1600 | 0.010 |
Why?
| Bronchoalveolar Lavage | 1 | 1996 | 98 | 0.010 |
Why?
| Heparin | 1 | 1997 | 240 | 0.010 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2000 | 466 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2000 | 1727 | 0.010 |
Why?
| Immunophenotyping | 1 | 1996 | 288 | 0.010 |
Why?
| Regional Blood Flow | 1 | 1997 | 427 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2001 | 1355 | 0.010 |
Why?
| HeLa Cells | 1 | 1996 | 609 | 0.010 |
Why?
| Calcimycin | 1 | 1994 | 58 | 0.010 |
Why?
| Mass Screening | 1 | 2001 | 1095 | 0.010 |
Why?
| Epidermal Growth Factor | 1 | 1994 | 173 | 0.010 |
Why?
| Adult | 2 | 2009 | 32385 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2006 | 4882 | 0.010 |
Why?
| Mice, Inbred C3H | 1 | 1994 | 256 | 0.010 |
Why?
| Interferon-beta | 1 | 1994 | 87 | 0.010 |
Why?
| Prognosis | 1 | 2001 | 3563 | 0.010 |
Why?
| Neoplasm Staging | 1 | 1997 | 1234 | 0.010 |
Why?
| Cell Survival | 1 | 1996 | 1075 | 0.010 |
Why?
| Macrophage Activation | 1 | 1994 | 169 | 0.010 |
Why?
| Analysis of Variance | 1 | 1993 | 1329 | 0.010 |
Why?
| Interferon-gamma | 1 | 1994 | 747 | 0.010 |
Why?
| Mutation | 1 | 2000 | 3493 | 0.010 |
Why?
| Peptides | 1 | 1994 | 893 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 1994 | 1181 | 0.010 |
Why?
| Retrospective Studies | 1 | 2005 | 13433 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|